{{header
 | title      = National Pediatric Research Network Act of 2013 ( S424 ; 113th Congress)
 | author     = 
 | related_author = United States Congress
 | translator = 
 | section    = 
 | previous   = 
 | next       = 
 | year       = 2013
 | month      = 02
 | day        = 28
 | notes      = ''{{USBill|113|s|424}}'' as introduced
 | categories =
 | portal     =
 | congress   = 113
 | session    = 1
 | title      = National Pediatric Research Network Act of 2013 ( S424 ; 113th Congress)
 | bill       = 424
 | billtype   = s
 | purpose    = To amend title IV of the Public Health Service Act to provide for a National Pediatric Research Network, including with respect to pediatric rare diseases or conditions.
 | wikipedia  =
}}

{{Center|113th CONGRESS}}


{{Center|1st Session}}


{{Center|S. 424}}


{{Center|IN THE SENATE OF THE UNITED STATES}}


{{Center|February 28, 2013}}


{{Center|
[[w:|Mr. Brown]] (for himself,
[[w:|Mr. Wicker]] ,
[[w:|Mr. Blumenthal]] ,
[[w:|Mr. Blunt]] ,
[[w:|Ms. Collins]] ,
[[w:|Mr. Portman]] , and
[[w:|Mr. Whitehouse]] ) introduced the following bill; which was read twice and referred to the [[w:United States Senate Committee on Health, Education, Labor, and Pensions|Committee on Health, Education, Labor, and Pensions]] }}


{{Center|A BILL}}

To amend title IV of the Public Health Service Act to provide for a National Pediatric Research Network, including with respect to pediatric rare diseases or conditions.

=Section 1. Short title=

This Act may be cited as the “National Pediatric Research Network Act of 2013” .

=Sec. 2. National Pediatric Research Network=

 Section 409D of the Public Health Service Act( [http://www.law.cornell.edu/uscode/text/42/284h 42 U.S.C. 284h] ; relating to the Pediatric Research Initiative)is amended—
:(1) by redesignating subsection (d)as subsection (f); and
:(2) by inserting after subsection (c)the following:

<blockquote>

===(d) National Pediatric Research Network– ===



====(1) Network– ====

In carrying out the Initiative, the [[w:National Institutes of Health|Director of NIH]] , in consultation with the [[w:National Institutes of Health|Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development]] and in collaboration with other appropriate national research institutes and national centers that carry out activities involving pediatric research, may provide for the establishment of a National Pediatric Research Network consisting of the pediatric research consortia receiving awards under paragraph (2).

====(2) Pediatric research consortia– ====



=====(A) In general– =====

The [[w:National Institutes of Health|Director of NIH]] may award funding, including through grants, contracts or other mechanisms, to public or private nonprofit entities—
:(i) for establishing or strengthening pediatric research consortia; and
:(ii) for providing support for such consortia, including with respect to—
::(I) basic, clinical, behavioral, or translational research to meet unmet pediatric research needs; and
::(II) training researchers in pediatric research techniques in order to address unmet pediatric research needs.

=====(B) Research– =====

The [[w:National Institutes of Health|Director of NIH]] may ensure that—
:(i) each consortium receiving an award under subparagraph (A)conducts or supports at least one category of research described in subparagraph (A)(ii)(I)and collectively such consortia conduct or support all such categories of research; and
:(ii) one or more such consortia provide training described in subparagraph (A)(ii)(II).

=====(C) Number of consortia– =====

The [[w:National Institutes of Health|Director of NIH]] may make awards under this paragraph for not more than 8 pediatric research consortia, with a minimum of one pediatric research consortium that prioritizes collaboration with institutions serving rural areas.

=====(D) Organization of consortium– =====

Each consortium receiving an award under subparagraph (A)shall—
:(i) be formed from a collaboration of cooperating institutions;
:(ii) be coordinated by a lead institution; and
:(iii) meet such requirements as may be prescribed by the [[w:National Institutes of Health|Director of NIH]] .

=====(E) Supplement, not supplant– =====

Any support received by a consortium under subparagraph (A)shall be used to supplement, and not supplant, other public or private support for activities authorized to be supported under this paragraph.

=====(F) Duration of consortium support– =====

Support of a consortium under subparagraph (A)may be for a period of not to exceed 5 years. Such period may be extended at the discretion of the [[w:National Institutes of Health|Director of NIH]] .

====(3) Coordination of consortia activities– ====

The [[w:National Institutes of Health|Director of NIH]] shall—
:(A) as appropriate, provide for the coordination of activities (including the exchange of information and regular communication) among the consortia established pursuant to paragraph (2); and
:(B) as appropriate, require the periodic preparation and submission to the [[w:National Institutes of Health|Director]] of reports on the activities of each such consortium.

===(e) Research on pediatric rare diseases or conditions– ===



====(1) In general– ====

In making awards under subsection (d)(2)for pediatric research consortia, the [[w:National Institutes of Health|Director of NIH]] may ensure that an appropriate number of such awards are awarded to such consortia that agree to—
:(A) focus primarily on pediatric rare diseases or conditions (including any such diseases or conditions that are genetic disorders or are related to birth defects); and
:(B) conduct or coordinate one or more multisite clinical trials of therapies for, or approaches to, the prevention, diagnosis, or treatment of one or more pediatric rare diseases or conditions..
</blockquote>

{{PD-USGov}}
[[Category:Proposed United States federal law]]
[[Category:Proposed United States federal law of the 113th Congress]]
